Tekla Life Sciences Investors
HQLNYSEFinancial Services● Active
$16.67
$-0.25(-1.48%)
Market Cap$506901360
P/E Ratio—
52W High$18.46
52W Low$12.34
Tekla Life Sciences Investors (HQL) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HQL · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.08M | $0.00M | $15.24M | $0.00M | $0.00M |
| Net Receivables | $1.14M | $0.23M | $5.04M | $0.62M | $0.15M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $1.25M | $0.28M | $5.05M | $0.62M | $0.14M |
| PP&E Net | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $515.38M | $460.58M | $402.60M | $414.73M | $534.19M |
| Liabilities | |||||
| Short-Term Debt | $0.00M | $0.00M | $0.00M | $11.09M | $10.04M |
| Accounts Payable | $0.72M | $0.00M | $0.00M | $5.10M | $0.15M |
| Total Current Liabilities | $0.72M | $0.89M | $0.00M | $5.10M | $10.75M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $1.73M | $0.89M | $0.67M | $16.82M | $10.75M |
| Stockholders Equity | |||||
| Retained Earnings | $77.60M | $44.13M | ($1.48M) | $9.55M | $150.70M |
| Total Stockholders Equity | $513.66M | $459.69M | $401.93M | $397.90M | $523.44M |
| Total Liab & Equity(computed) | $515.38M | $460.58M | $402.60M | $414.73M | $534.19M |
| Debt Summary | |||||
| Total Debt | $0.00M | $0.00M | $0.00M | $11.09M | $1.34M |
| Net Debt | ($0.08M) | $0.00M | ($0.00M) | $0.01M | $1.34M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Tekla Life Sciences Investors data
About Tekla Life Sciences Investors (HQL) Balance Sheet
Tekla Life Sciences Investors (HQL) balance sheet shows total assets of $0.52B with cash of $0.00B. Total liabilities are $0.00B, total debt $0.00B, and stockholders equity $0.51B.
Frequently asked questions
HQL · 4 questionsTekla Life Sciences Investors has total debt of $0.00B with net debt of ($0.00B).
HQL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10